title: [Old drugs and new approval procedures: Akrinor remains marketable and an application for reapproval of Arginin Vasopressin has been made].
authors.affiliation: Klinik und Poliklinik für Anästhesiologie und Intensivtherapie, Universitätsklinikum Carl Gustav Carus, Technische Universität, Fetscherstrasse 74, 01307 Dresden. thea.koch@uniklinikum-dresden.de
authors.forename: T
authors.initials: T
authors.lastname: Koch
authors.forename: V
authors.initials: V
authors.lastname: Wenzel
mesh_terms: D001127:Arginine Vasopressin / Q000627:therapeutic use*; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D003422:Critical Care; D017277:Drug Approval; D004338:Drug Combinations; D004345:Drug Industry; D005858:Germany; D006801:Humans; D013806:Theophylline / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014662:Vasoconstrictor Agents / Q000627:therapeutic use*
chemical_list: D002317:Cardiovascular Agents; D004338:Drug Combinations; D014662:Vasoconstrictor Agents; D001127:Arginine Vasopressin; C000147:cafedrine, theodrenaline drug combination; D013806:Theophylline